MBRX

Moleculin Biotech (MBRX)

About Moleculin Biotech (MBRX)

Moleculin Biotech, Inc. is a clinical stage pharmaceutical company. It engages in the business of growing a pipeline including phase 2 clinical programs for hard-to-treat cancers and viruses. The company was founded by Walter V. Klemp, Donald H. Picker, and Waldemar Priebe in July 2015 and is headquartered in Houston, TX.

Details

Daily high
$4.78
Daily low
$4.36
Price at open
$4.47
52 Week High
$91.25
52 Week Low
$4.36
Market cap
9.3M
Dividend yield
0.00%
Volume
103,211
Avg. volume
322,281
P/E ratio
-.07

Moleculin Biotech News

Details

Daily high
$4.78
Daily low
$4.36
Price at open
$4.47
52 Week High
$91.25
52 Week Low
$4.36
Market cap
9.3M
Dividend yield
0.00%
Volume
103,211
Avg. volume
322,281
P/E ratio
-.07